Literature DB >> 34080723

Semiparametric regression analysis of partly interval-censored failure time data with application to an AIDS clinical trial.

Qingning Zhou1, Yanqing Sun1, Peter B Gilbert2,3.   

Abstract

Failure time data subject to various types of censoring commonly arise in epidemiological and biomedical studies. Motivated by an AIDS clinical trial, we consider regression analysis of failure time data that include exact and left-, interval-, and/or right-censored observations, which are often referred to as partly interval-censored failure time data. We study the effects of potentially time-dependent covariates on partly interval-censored failure time via a class of semiparametric transformation models that includes the widely used proportional hazards model and the proportional odds model as special cases. We propose an EM algorithm for the nonparametric maximum likelihood estimation and show that it unifies some existing approaches developed for traditional right-censored data or purely interval-censored data. In particular, the proposed method reduces to the partial likelihood approach in the case of right-censored data under the proportional hazards model. We establish that the resulting estimator is consistent and asymptotically normal. In addition, we investigate the proposed method via simulation studies and apply it to the motivating AIDS clinical trial.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  AIDS clinical trial; EM algorithm; partly interval-censored data; semiparametric transformation models; survival analysis

Mesh:

Year:  2021        PMID: 34080723      PMCID: PMC9080514          DOI: 10.1002/sim.9035

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  12 in total

1.  A multiple imputation approach to Cox regression with interval-censored data.

Authors:  W Pan
Journal:  Biometrics       Date:  2000-03       Impact factor: 2.571

2.  Generalized log-rank tests for partly interval-censored failure time data.

Authors:  Xingqiu Zhao; Qiang Zhao; Jainguo Sun; Jong S Kim
Journal:  Biom J       Date:  2008-06       Impact factor: 2.207

3.  Maximum likelihood estimation for semiparametric transformation models with interval-censored data.

Authors:  Donglin Zeng; Lu Mao; D Y Lin
Journal:  Biometrika       Date:  2016-05-24       Impact factor: 2.445

4.  A proportional hazards model for interval-censored failure time data.

Authors:  D M Finkelstein
Journal:  Biometrics       Date:  1986-12       Impact factor: 2.571

5.  A flexible, computationally efficient method for fitting the proportional hazards model to interval-censored data.

Authors:  Lianming Wang; Christopher S McMahan; Michael G Hudgens; Zaina P Qureshi
Journal:  Biometrics       Date:  2015-09-22       Impact factor: 2.571

6.  A multiple imputation approach to the analysis of interval-censored failure time data with the additive hazards model.

Authors:  Ling Chen; Jianguo Sun
Journal:  Comput Stat Data Anal       Date:  2010-04-01       Impact factor: 1.681

7.  A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.

Authors:  S M Hammer; D A Katzenstein; M D Hughes; H Gundacker; R T Schooley; R H Haubrich; W K Henry; M M Lederman; J P Phair; M Niu; M S Hirsch; T C Merigan
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

8.  Semiparametric Regression Analysis of Multiple Right- and Interval-Censored Events.

Authors:  Fei Gao; Donglin Zeng; David Couper; D Y Lin
Journal:  J Am Stat Assoc       Date:  2018-08-17       Impact factor: 5.033

9.  HIV-1 RNA, CD4 cell count and the risk of progression to AIDS and death during treatment with HIV-1 reverse transcriptase inhibitors.

Authors:  S Staszewski; R DeMasi; A M Hill; D Dawson
Journal:  AIDS       Date:  1998-10-22       Impact factor: 4.177

10.  Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshop.

Authors:  J M Albert; J P Ioannidis; P Reichelderfer; B Conway; R W Coombs; L Crane; R Demasi; D O Dixon; P Flandre; M D Hughes; L A Kalish; K Larntz; D Lin; I C Marschner; A Muñoz; J Murray; J Neaton; C Pettinelli; W Rida; J M Taylor; S L Welles
Journal:  Stat Med       Date:  1998-11-15       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.